Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 91 (ZNF91) is a human transcription factor belonging to the zinc finger protein family, specifically of the KRAB (Kruppel-associated box) subfamily. It functions as a transcriptional repressor and plays an important role in gene regulation, notably in silencing transposable elements such as SINE-VNTR-Alu (SVA) retrotransposons by binding to their DNA sequences and recruiting chromatin-modifying complexes. Zinc finger protein 91 is a nuclear transcription factor encoded at chromosome 19 (region 23,304,991-23,395,501, reverse strand). It contains multiple zinc finger domains—structural motifs that bind DNA and enable the protein to regulate gene expression. ZNF91 is a member of the KRAB domain family, enabling it to recruit transcriptional co-repressor complexes such as TRIM28/KAP1 and establish specific gene silencing, particularly of SVA retrotransposons. In addition to retrotransposon silencing, ZNF91 may regulate the expression of promoters such as FCGR2B, although supporting evidence remains incomplete. Mutations or dysregulation of ZNF91 and other zinc finger proteins have been linked to cancer biology (e.g., hepatocellular carcinoma) and neurodevelopmental disorders. As is typical for transcription factors, it exerts pleiotropic control over cell processes, and its role in disease may reflect broader zinc finger protein functions, including cell cycle regulation, apoptosis, and stem cell maintenance. No drugs currently target ZNF91 directly, but molecules that modulate transcription factor activity or chromatin interactions could theoretically influence its function. Direct manipulation of ZNF91 must consider potential safety concerns due to its fundamental role in genome regulation.
Drug mechanisms would hypothetically include inhibition of transcriptional repression or modulation of chromatin state at ZNF91 binding sites
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 91 (ZNF91).